Northwestern UniversityOffice for Research

Northwestern University - Office for Research

Past Events

Below is a list of past events. View the current listing of upcoming events.

December 4, 2012 - 5:00pm
INVO invites you to attend a free seminar on how to successfully commercialize mobile phone apps in the healthcare space.
December 4, 2012 - 7:00am
10th Annual MidAmerica Healthcare Venture Forum unites active investors with business development executives to syndicate investment opportunities with Mid-America based start-ups.
November 14, 2012 - 6:00pm
Ayers College of Commerce and Industry (CCI) presents a Symposium focused on the meeting of the economy and green and sustainable initiatives.
November 8, 2012 - 5:30pm
This forum provides a platform for female executives to share their insights with others across the life science industry seeking advice on how to advance their careers and move into positions of greater responsibility.
November 7, 2012 - 3:30pm
The Research Commercialization Introductory Course is a very popular online course designed to help science and engineering researchers better understand how research commercialization works
October 25, 2012 - 4:30pm
Where: Ford Building, ITW Room (Second Floor) What to Bring: Questions. Lots of them. Refreshments Will be Served!
October 24, 2012 - 11:30am
Whether you are a university spinout or a start-up company interested in out-licensing part of your technology, licensing can be an important factor at early stage life sciences companies.
October 16, 2012 - 5:15pm
Justin Gillis is a reporter covering environmental science and policy for The New York Times. He was a finalist for the Pulizer Prize in 1989 for an article on hidden land dealings by the top country government official in Miami
October 11, 2012 - 10:00am
CATTEC V brings together Midwest talent, ideas and capital in a showcase of emerging high tech startups from Midwest universities and accelerators.
October 10, 2012 - 11:30am
For most early-stage life sciences companies, beginning Clinical Phase II trials is a significant milestone and exciting development. But getting to this point can be daunting, difficult, expensive and lengthy.